U.S. overdose deaths fell while emergency crews responded to fewer nonfatal opioid overdoses and recorded fewer naloxone administrations, according to a study reported by Science News. The pattern challenges the idea that more naloxone rescues were the main reason deaths dropped. Science News puts annual deaths from all drug overdoses at around 111,000 at a mid-2023 peak and under 71,000 by the end of 2025.
The researchers analyzed nearly 186 million emergency medical services (EMS) activations nationwide from May 2020 through December 2025, Science News reports. An activation is an ambulance or other EMS response after a 911 call, not a count of every overdose. Of 2.5 million responses for nonfatal drug overdoses, 40.5 percent involved opioids. From May 2023 onward, EMS activations for nonfatal opioid overdoses fell on average by about 6,000, or around 33 percent, below expected levels. Total naloxone administrations in the studied EMS data dropped by around 4,700 on average, or 21 percent, below expected levels.
The researchers interpret those declines as a sign that fewer overdoses occurred, rather than that naloxone reversed more of them. But the study did not include cases in which a bystander administered naloxone and nobody called 911. Its EMS figures therefore cannot account for every community rescue.
Michael Barnett, a researcher at Brown University School of Public Health, told Science News that “Naloxone still saves lives every day,” but “it doesn’t look like the reason for the sudden turn” in overdose deaths. In a STAT opinion piece, Barnett, J. Travis Donahoe and David T. Zhu argue that neither expanded naloxone use nor incremental gains in medication treatment fit the timing or scale of the decline. Barnett separately offered his view to Science News that a disruption in the fentanyl supply best explains the turn. That is a proposed explanation, not a finding of the EMS analysis.
Comments